Dr. Jeff Ross more than 20 years of biomedical research, management and regulatory experience in regenerative medicine, biologics, and medical devices including concept development, preclinical, clinical, manufacturing, and commercialization. He has held various positions at Guidant, Athersys and SurModics and is currently on the Board of Directors for the Alliance of Regenerative Medicine (ARM). Since joining Miromatrix in 2010 he has been pivotal in the development, manufacturing and regulatory clearance of the innovative MIROMESH and MIRODERM product lines. He has spearheaded development, global patent strategy, and fundraising for the revolutionary whole organ transplant program and its key decellularization technology. Dr. Ross has over 35 patents along with scientific publications in Nature and other peer reviewed journals. He holds a Master’s degree in Biomedical Engineering and a Ph.D. in Molecular, Cellular and Developmental Biology from the University of Minnesota.